Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19845488 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845486 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845445 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845542 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845487 | 0.95 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845475 | 0.94 | KDM4E (0.43) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845437 | 0.94 | KDM4E (0.43) | KDM4EATML3MBTL1PTGER4PDE10A | |
| SCHEMBL19845188 | 0.92 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL19845179 | 0.92 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4TSPO | |
| SCHEMBL19845262 | 0.92 | KDM4E (0.42) | KDM4EATML3MBTL1PTGER4TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037574-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, ETV6, LEF1 | KDM4E 2538/4885ATM 3035/4885L3MBTL1 3274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.